Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
Titel:
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
Auteur:
Armstrong, Andrew J Halabi, Susan Eisen, Tim Broderick, Samuel Stadler, Walter M Jones, Robert J Garcia, Jorge A Vaishampayan, Ulka N Picus, Joel Hawkins, Robert E Hainsworth, John D Kollmannsberger, Christian K Logan, Theodore F Puzanov, Igor Pickering, Lisa M Ryan, Christopher W Protheroe, Andrew Lusk, Christine M Oberg, Sadie George, Daniel J